Bray Capital Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-348
| Closed | -$10K | – | 280 |
|
|
2022
Q3 | $10K | Hold |
348
| – | – | ﹤0.01% | 257 |
|
|
2022
Q2 | $19K | Hold |
348
| – | – | 0.01% | 226 |
|
|
2022
Q1 | $19K | Hold |
348
| – | – | ﹤0.01% | 232 |
|
|
2021
Q4 | $19K | Hold |
348
| – | – | ﹤0.01% | 235 |
|
|
2021
Q3 | $17K | Hold |
348
| – | – | ﹤0.01% | 234 |
|
|
2021
Q2 | $17K | Hold |
348
| – | – | ﹤0.01% | 231 |
|
|
2021
Q1 | $16K | Hold |
348
| – | – | ﹤0.01% | 234 |
|
|
2020
Q4 | $16K | Hold |
348
| – | – | ﹤0.01% | 234 |
|
|
2020
Q3 | $16K | Hold |
348
| – | – | 0.01% | 223 |
|
|
2020
Q2 | $18K | Hold |
348
| – | – | 0.01% | 217 |
|
|
2020
Q1 | $16K | Hold |
348
| – | – | 0.01% | 216 |
|
|
2019
Q4 | $20K | Hold |
348
| – | – | 0.01% | 222 |
|
|
2019
Q3 | $19K | Hold |
348
| – | – | 0.01% | 226 |
|
|
2019
Q2 | $17K | Hold |
348
| – | – | 0.01% | 242 |
|
|
2019
Q1 | $18K | Hold |
348
| – | – | 0.01% | 235 |
|
|
2018
Q4 | $17K | Hold |
348
| – | – | 0.01% | 238 |
|
|
2018
Q3 | $17K | Hold |
348
| – | – | 0.01% | 243 |
|
|
2018
Q2 | $18K | Buy |
+348
| New | +$18K | 0.01% | 291 |
|
|
2015
Q3 | – | Sell |
-4,095
| Closed | -$213K | – | 407 |
|
|
2015
Q2 | $213K | Hold |
4,095
| – | – | 0.12% | 126 |
|
|
2015
Q1 | $236K | Sell |
4,095
-880
| -18% | -$50.7K | 0.14% | 126 |
|
|
2014
Q4 | $266K | Buy |
+4,975
| New | +$266K | 0.17% | 122 |
|